Concert Pharmaceuticals
Ms. Christine Boisclair joined Concert in June 2016 as Vice President, Regulatory Affairs and Quality Assurance with more than 30 years Regulatory Affairs experience in the biopharmaceutical industry and across multiple therapeutic areas. Prior to joining Concert, Ms. Boisclair was Vice President, Regulatory Affairs at Forum Pharmaceuticals. Before joining Forum Pharmaceuticals Ms. Boisclair held management roles at several companies including Insmed Inc, Agennix Inc, OSI Pharmaceuticals Inc, Genzyme Corporation, Immulogic Pharmaceuticals and Parexel International. Ms. Boisclair began her regulatory career at Searle Pharmaceuticals and Glaxo in the UK.She received a Bachelor of Science Honors Degree in Biochemistry from the University of York in the United Kingdom.
This person is not in any offices
Concert Pharmaceuticals
Concert Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs.